
Ocef TM Junior 250mg/31.25mg Injection
Marketer
SBS Biosciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Ocef TM Junior 250mg/31.25mg Injection
Cefixime and Sulbactam Pediatric Injection (250mg/31.25mg) is a dual-action antibiotic. This medication combats various bacterial infections by inhibiting microbial growth and propagation. Administration must be strictly under a physician's guidance. Consistent adherence to the prescribed dosage schedule is crucial; premature discontinuation may compromise treatment efficacy. Complete the full course, even with symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand immediate emergency care. Inform your doctor about all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior physician consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration contribute to faster recovery. Your doctor might order lab tests to monitor therapeutic response.
Primary Ingredients of Ocef TM Junior 250mg/31.25mg Injection
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Ocef TM Junior 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ocef TM Junior 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ocef TM Junior 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ocef TM Junior 250mg/31.25mg Injection:
Administering this medication will be handled by your physician or their registered nurse; please do not self-medicate.
How Ocef TM Junior 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Ocef TM Junior 250mg/31.25mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ocef TM Junior 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation Ocef TM Junior (250mg/31.25mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to fetuses; however, clinical data from human studies remain scarce.
Breast feedingCAUTION
The administration of Ocef TM Junior 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ocef TM Junior 250mg/31.25mg Injection may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ocef TM Junior 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The 250mg/31.25mg Ocef TM Junior Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for this injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ocef TM Junior 250mg/31.25mg Injection :
Should you forget to administer a dose of Ocef TM Junior 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Ocef TM Junior 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
